Label-free imaging of gelatin-containing hydrogel scaffolds

Biomaterials

Volumn 42, Issue , 2015, Pages 144-150

  Liang, Yajie ^a   Bar Shir, Amnon ^a   Song, Xiaolei ^a   Gilad, Assaf A ^a   Walczak, Piotr ^a   Bulte, Jeff W M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CEST MRI; Gelatin; Hyaluronic acid; Hydrogel; Scaffold; Transplantation

Indexed keywords

AMIDES; BIODEGRADATION; HYALURONIC ACID; HYDROGELS; MAMMALS; ORGANIC ACIDS; SCAFFOLDS; SCAFFOLDS (BIOLOGY); STEM CELLS; TRANSPLANTATION (SURGICAL);

CEST MRIS; CHEMICAL EXCHANGE SATURATION TRANSFER; FLUORESCENT MICROSCOPY; GELATIN; HYDROGEL SCAFFOLDS; LABEL-FREE IMAGING; NON-INVASIVE IMAGING; POLYETHYLENE GLYCOL DIACRYLATE;

MAGNETIC RESONANCE IMAGING;

GELATIN; HYALURONIC ACID; MACROGOL; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CHEMICAL COMPOSITION; CHEMICAL EXCHANGE SATURATION TRANSFER MAGNETIC RESONANCE IMAGING; CHEMICAL STRUCTURE; CONTROLLED STUDY; DECOMPOSITION; DEGRADATION; ENZYME ACTIVITY; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STEM CELL TRANSPLANTATION; TISSUE SCAFFOLD; ANIMAL; CHEMISTRY; IMPLANT; MALE; PHARMACOLOGY; STAINING; THREE DIMENSIONAL IMAGING;

ALEXA; MUS;

ANIMALS; GELATIN; HYDROGEL; IMAGING, THREE-DIMENSIONAL; IMPLANTS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MALE; MICE; STAINING AND LABELING; TISSUE SCAFFOLDS;

EID: 84919648104     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.050     Document Type: Article

References (30)

1. Elisseeff J. Hydrogels: structure starts to gel. Nat Mater 2008, 7:271-273.
2. Wang C., Varshney R.R., Wang D.A. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv Drug Deliv Rev 2010, 62:699-710.
3. Burdick J.A., Prestwich G.D. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011, 23:H41-H56.
4. Shu X.Z., Ahmad S., Liu Y., Prestwich G.D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. JBiomed Mater Res A 2006, 79:902-912.
5. Zhong J., Chan A., Morad L., Kornblum H.I., Fan G., Carmichael S.T. Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil Neural Repair 2010, 24:636-644.
6. Liang Y., Walczak P., Bulte J.W. The survival of engrafted neural stem cells within hyaluronic acid hydrogels. Biomaterials 2013, 34:5521-5529.
7. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
8. Seidlits S.K., Khaing Z.Z., Petersen R.R., Nickels J.D., Vanscoy J.E., Shear J.B., et al. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation. Biomaterials 2010, 31:3930-3940.
9. Alsberg E., von Recum H.A., Mahoney M.J. Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther 2006, 6:847-866.
10. Chowdhury F., Na S., Li D., Poh Y.C., Tanaka T.S., Wang F., et al. Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells. Nat Mater 2010, 9:82-88.
11. Lai C.Y., Wu P.J., Roffler S.R., Lee S.T., Hwang S.M., Wang S.S., et al. Clearance kinetics of biomaterials affects stem cell retention and therapeutic efficacy. Biomacromolecules 2014, 15:564-573.
12. Ward K.M., Aletras A.H., Balaban R.S. Anew class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). JMagn Reson 2000, 143:79-87.
13. van Zijl P.C., Yadav N.N. Chemical exchange saturation transfer (CEST): what is in a name and what isn't?. Magn Reson Med 2011, 65:927-948.
14. Chan K.W., Liu G., Song X., Kim H., Yu T., Arifin D.R., et al. MRI-detectable pH nanosensors incorporated into hydrogels for invivo sensing of transplanted-cell viability. Nat Mater 2013, 12:268-275.
15. Gilad A.A., McMahon M.T., Walczak P., Winnard P.T., Raman V., van Laarhoven H.W., et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007, 25:217-219.
16. Airan R.D., Bar-Shir A., Liu G., Pelled G., McMahon M.T., van Zijl P.C., et al. MRI biosensor for protein kinase A encoded by a single synthetic gene. Magn Reson Med 2012, 68:1919-1923.
17. Bar-Shir A., Liu G., Chan K.W., Oskolkov N., Song X., Yadav N.N., et al. Human protamine-1 as an MRI reporter gene based on chemical exchange. ACS Chem Biol 2014, 9:134-138.
18. Liu G., Liang Y., Bar-Shir A., Chan K.W., Galpoththawela C.S., Bernard S.M., et al. Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. JAm Chem Soc 2011, 133:16326-16329.
19. Chan K.W., Liu G., van Zijl P.C., Bulte J.W., McMahon M.T. Magnetization transfer contrast MRI for non-invasive assessment of innate and adaptive immune responses against alginate-encapsulated cells. Biomaterials 2014, 35:7811-7818.
20. Goffeney N., Bulte J.W., Duyn J., Bryant L.H., van Zijl P.C. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. JAm Chem Soc 2001, 123:8628-8629.
21. Eastoe J.E. The amino acid composition of mammalian collagen and gelatin. Biochem J 1955, 61:589-600.
22. Sugiyama K., Yamamoto K., Kamata O., Katsuda N. Asimple and rapid assay for collagenase activity using fluorescence-labeled substrate. Kurume Med J 1980, 27:63-69.
23. Mun-Bryce S., Rosenberg G.A. Matrix metalloproteinases in cerebrovascular disease. JCereb Blood Flow Metab 1998, 18:1163-1172.
24. Deryugina E.I., Bourdon M.A., Reisfeld R.A., Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998, 58:3743-3750.
25. Haas T.L., Davis S.J., Madri J.A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. JBiol Chem 1998, 273:3604-3610.
26. Fukuda Y., Ishizaki M., Kudoh S., Kitaichi M., Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998, 78:687-698.
27. Candelario-Jalil E., Yang Y., Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994.
28. Wang X., Li K.F., Adams E., Van Schepdael A. Matrix metalloproteinase inhibitors: a review on bioanalytical methods, pharmacokinetics and metabolism. Curr Drug Metab 2011, 12:395-410.
29. Srivastava A.K., Bulte J.W. Seeing stem cells at work invivo. Stem Cell Rev 2014, 10:127-144.
30. Gilad A.A., van Laarhoven H.W., McMahon M.T., Walczak P., Heerschap A., Neeman M., et al. Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. Magn Reson Med 2009, 61:970-974.